SCHEMBL10236445

SCHEMBL10236445

CCOP(=O)(Nc1cc(-c2ccc(C#CC3=CCC=N3)cc2)sc1C(=O)O)c1ccc(Cl)cc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10237247 0.86 MEN1 (0.38) —
SCHEMBL10237268 0.85 PTPN1 (0.49) —
SCHEMBL10237067 0.84 PTPN1 (0.41) —
SCHEMBL10237267 0.84 PTPN1 (0.41) —
SCHEMBL10236447 0.82 — —
SCHEMBL10236463 0.82 — —
SCHEMBL10237220 0.81 PTPN1 (0.46) —
SCHEMBL10237270 0.81 IGF2BP2 (0.45) —
SCHEMBL10279076 0.80 — —
SCHEMBL10237244 0.79 RXFP1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193372-B2 Phosphothiophene and phosphothiazole HCV polymerase inhibitors IDENIX PHARMACEUTICALS, INC. (US) 2012-06-05 — — US disclosed
Send feedback